BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAK7 Class: NOTE 1.250% 5/1

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's Holding History (CIK: 0001694217)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 13,450,000 Value ($000) $12,918 Avg Close Range
Q3 2025
Shares 13,450,000 Value ($000) $12,733 Avg Close Range
Q2 2025
Shares 14,150,000 Value ($000) $13,251 Avg Close Range
Q1 2025
Shares 13,800,000 Value ($000) $13,035 Avg Close Range
Q4 2024
Shares 13,800,000 Value ($000) $12,810 Avg Close Range
Q3 2024
Shares 13,800,000 Value ($000) $13,114 Avg Close Range
Q2 2024
Shares 14,250,000 Value ($000) $13,647 Avg Close Range
Q1 2024
Shares 13,950,000 Value ($000) $13,853 Avg Close Range
Q4 2023
Shares 13,950,000 Value ($000) $14,325 Avg Close Range
Q3 2023
Shares 14,450,000 Value ($000) $14,348 Avg Close Range
Q2 2023
Shares 14,450,000 Value ($000) $14,575 Avg Close Range
Q1 2023
Shares 14,450,000 Value ($000) $15,024 Avg Close Range
Q4 2022
Shares 13,700,000 Value ($000) $14,809 Avg Close Range
Q3 2022
Shares 13,700,000 Value ($000) $13,605 Avg Close Range
Q2 2022
Shares 12,000,000 Value ($000) $11,926 Avg Close Range
Q1 2022
Shares 12,000,000 Value ($000) $12,005 Avg Close Range
Q4 2021
Shares 15,700,000 Value ($000) $16,340 Avg Close Range
Q3 2021
Shares 15,700,000 Value ($000) $15,546 Avg Close Range
Q2 2021
Shares 15,700,000 Value ($000) $15,731 Avg Close Range